Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D)
This study is ongoing, but not recruiting participants.
Study NCT00006305 Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: September 28, 2000 Last Updated: February 19, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Disease
Cardiovascular Diseases
Heart Diseases
Insulin Resistance
Diabetes Mellitus
Additional conditions recognized in this trial
Coronary Artery Disease
Diabetes Mellitus, Type 2
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Endocrine System Diseases
Glucose Metabolism Disorders
Hyperinsulinism
Metabolic Diseases
Myocardial Ischemia
Vascular Diseases
Interventions listed in this trial
Coronary Artery Bypass
Biguanides, thiazolidinediones
Insulin, sulfonylurea
Additional drug interventions recognized in this trial
2,4-thiazolidinedione
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Calcium Channel Blockers
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Cardiovascular Agents
Enzyme Inhibitors
Hypoglycemic Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Back to top of Main Content
